PT - JOURNAL ARTICLE AU - Marc Kipping AU - Dirk Tänzler AU - Andrea Sinz TI - A Rapid and Reliable Liquid Chromatography/Mass Spectrometry Method for SARS-CoV-2 Diagnostics from Gargle Solutions and Saliva AID - 10.1101/2021.05.05.21256257 DP - 2021 Jan 01 TA - medRxiv PG - 2021.05.05.21256257 4099 - http://medrxiv.org/content/early/2021/05/07/2021.05.05.21256257.short 4100 - http://medrxiv.org/content/early/2021/05/07/2021.05.05.21256257.full AB - We describe a rapid liquid chromatography/mass spectrometry (LC/MS) method for the direct detection and quantitation of SARS-CoV-2 nucleoprotein in gargle solutions and saliva. The method is based on a multiple-reaction monitoring (MRM) mass spectrometry approach with a total cycle time of 5 minutes per analysis and allows the detection and accurate quantitation of SARS-CoV-2 nucleoprotein as low as 500 amol/µl. We improved the sample preparation protocol of our recent piloting SARS-CoV-2 LC/MS study regarding sensitivity, reproducibility, and compatibility with a complementary reverse transcriptase quantitative polymerase chain reaction (RT-qPCR) analysis of the same sample. The aim of this work is to promote diagnostic tools that allow identifying and monitoring SARS-CoV-2 infections by LC/MS methods in a routine clinical environment.Competing Interest StatementThe authors have declared no competing interest.Funding StatementDeutsche Forschungsgemeinschaft: RTG 2467, project number 391498659, Intrinsically Disordered Proteins: Molecular Principles, Cellular Functions, and Diseases, Region of Saxony-Anhalt, Martin Luther University Halle-Wittenberg, Center for Structural Mass SpectrometryAuthor DeclarationsI confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.YesThe details of the IRB/oversight body that provided approval or exemption for the research described are given below:The oversight body is the "Ethik-Kommission der Medizinischen Fakultaet der Martin-Luther-Universitaet Halle-Wittenberg". They consider our work as follows: Announcement of this work is sufficient at the safety officers at the Martin Luther University Halle-Wittenberg and the regional authority at Magdeburg, Germany.All necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived.YesI understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).Yes I have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.YesAll data referred to in the manuscript are in the Supplementary Informaion.ACNAcetonitrilectCycle timeESIElectrospray ionizationFAFormic acidFASPFilter-aided sample preparationHPLCHigh-performance liquid chromatographyLCLiquid chromatographyLODLimit of detectionLOQLimit of quantitationMRMMultiple-reaction monitoringMSMass spectrometryMS/MSTandem mass spectrometryRT-qPCRReverse transcription quantitative polymerase chain reactionTFATrifluoroacetic acidUPLCUltra high-performance liquid chromatography